Skip to main content

Table 2 Demographic and laboratory data of the studied population (n = 117)

From: Can bilirubin/albumin ratio predict neurodevelopmental outcome in severe neonatal hyperbilirubinemia? A 3-month follow up study

Characteristics  
Male 70 (59.8%)
Gestational age (weeks) 37.8 ± 0.6
Weight (g) 2906 ± 443
Maternal diabetes 4 (3.4%)
Onset of jaundice (days) 2.9 ± 1.35
Age at admission (days) 5.52 ± 2.7
Bilirubin on admission (mg/dl) 25 (22–28.7)
Albumin on admission (g/dl) 3.4 (3.2–3.4)
Bilirubin/albumin ratio (mg/dl) 7.3 (6.4–8.9)
Reticulocyte count % 4.2 (1.7–12)
Positive Coombs test 34 (40%)
Rh Incompatibility 9 (7.69%)
ABO Incompatibility 35 (29.9%)
Suspected Sepsis 2 (1.7 %)
BIND score on admission
 0–3 113
 4–7 4
 Conventional (double) phototherapy 10 (8.5%)
 Intensive phototherapy 107 (91.5%)
 Exchange transfusion 18 (15.4%)
BIND score on discharge
 0–3 116
 4–7 (ABE) 1
Neurological outcome at 3 months
 Normal 105 (89.7%)
 Kernicterus 7 (6%)
 Missed follow up 5 (4.3%)
  1. Sepsis was suspected if there were clinical signs of sepsis associated with positive blood culture OR 2 of the following (a) elevated CRP, (b) total leucocytic count > 25,000 or < 5000, (c) immature to total neutrophil of ratio > 0.2, and (d) band count > 10%